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eart Failure With Normal Ejection Fraction:
he Complementary Roles of Echocardiography
nd CMR Imaging
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delaide, Australia
eart failure with normal ejection fraction (HFNEF), previously referred to as diastolic heart failure, has
ncreased in prevalence as a cause of heart failure, now accounting for up to 50% of all cases. Contrary
o initial evidence, the prognostic outlook in HFNEFmay be similar to that of heart failurewith reduced
jection fraction. According to current consensus statements, the diagnosis of HFNEF requires the
emonstration of relatively preserved systolic left ventricular function and evidence of diastolic
ysfunction. Noninvasive imaging techniques now permit evaluation of these parameters without
eed for cardiac catheterization in the large majority of patients. Echocardiography is the modality of
hoice in the evaluation of diastolic function but suffers from limitations in its assessment of systolic
unction. Cardiac magnetic resonance (CMR) imaging is the gold standard in the volumetric quantifi-
ation of systolic function; however, it has limitations in its ability to characterize diastolic function.
his report aims to review the strengths and weaknesses of both imaging modalities in the diagnosis
f HFNEF. With regards to echocardiography, it will specifically describe limitations in measuring left
entricular ejection fraction, describe novel techniques to assess systolic function such as tissue
elocity and strain analysis, and will review the measurements used in the evaluation of diastolic
unction. With respect to CMR, this review will highlight its value in the assessment of systolic left
entricular function, will review ancillary CMR findings that may support the diagnosis of HFNEF such
s tissue characterization, and will provide a brief overview of CMR techniques to assess diastolic
unction. We propose that these 2 modalities may play a complementary role in the diagnosis of
FNEF. The importance of imaging in the diagnosis of HFNEF extends to both the individual patient
nd to clinical trials of therapies for this condition. (J Am Coll Cardiol Img 2010;3:409–20) © 2010 by
he American College of Cardiology Foundation
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410eart failure with normal ejection fraction
(HFNEF) refers to the clinical syndrome of
heart failure in the presence of normal left
ventricular (LV) ejection fraction. Three
onditions must be fulfilled for its diagnosis: 1) the
resence of symptoms or signs of heart failure;
) the presence of normal or mildly abnormal
ystolic function; and 3) evidence of diastolic LV
ysfunction (1). With the aging population, and
ncreasing prevalence of hypertension, diabetes, and
besity, HFNEF now accounts for up to 50% of all
ases (2). Despite initial studies suggesting a
etter prognosis than heart failure with reduced
jection fraction (HFREF), more recent evidence
uggests similar prognostic outlook with both
ntities (3). A recent consensus statement pro-
osed replacement of the terms systolic and dia-
stolic heart failure with HFREF and
HFNEF, respectively, as the former im-
plies mutually exclusive mechanisms,
whereas diastolic dysfunction is highly
prevalent in systolic heart failure (4), and
there is evidence to suggest reduced
systolic tissue velocities in diastolic heart
failure (5). Moreover, published guide-
lines on the diagnosis of HFNEF (1)
uniformly require objective evidence of
diastolic LV dysfunction in addition to
clinical features of heart failure and LV
ejection fraction (LVEF) 50%. Thus,
imaging modalities play a pivotal role in
2 of the 3 diagnostic criteria of HFNEF.
Recent advances in echocardiographic
and cardiac magnetic resonance (CMR)
imaging techniques allow more accurate
characterization of cardiac structure and
unction, and permit more certain diagnosis of
FNEF.
athophysiology of Diastolic Dysfunction
t a macroscopic level, HFNEF is distinguished
rom HFREF by concentric LV remodeling rather
han eccentric. Concentric remodeling refers to
aintenance or increase in LV wall thickness rela-
ive to chamber size (Fig. 1), whereas in eccentric
emodeling, there is LV cavity dilation, and relative
all thickness is diminished.
Diastolic dysfunction is characterized patho-
hysiologically by increased LV stiffness (6). Con-
equently, with exercise, there is an inability to
ugment LV end-diastolic volume despite increas-
ionng LV end-diastolic pressure. The outcome of fncreased LV stiffness is reflected in the hemodynamic
hanges that are most widely used to assess diastolic
unction. In normal diastole, LV untwisting—a vig-
rous and active process—sucks blood from the left
trium into the left ventricle. Seventy percent to
0% of LV filling under these circumstances occurs
n early diastole, with atrial contraction accounting
or the remaining 20% to 30%. With the develop-
ent of early diastolic dysfunction, the proportion
f LV filling permitted to occur in early diastole is
educed. The relative importance of atrial contrac-
ion is thus increased—so-called grade I diastolic
ysfunction. As diastolic dysfunction worsens, pres-
ure mounts within the left atrium, such that
mmediately following mitral valve opening, blood
s forced under positive pressure, rather than sucked
y negative pressure, into the left ventricle. Al-
hough the proportion of LV filling occurring in
arly diastole returns to normal, the underlying
hysiology is not normal, hence the designation of
seudonormal LV filling, or grade II diastolic dys-
Figure 1. Short-Axis White Blood CMR Image Demonstrating
Concentric LVH
This end-diastolic short-axis cine cardiac magnetic resonance
(CMR) image demonstrates concentric thickening of the left ven-
tricular walls. The high spatial resolution and signal-to-noise
ratio of cardiac magnetic resonance allows tightly reproducible
measurement of left ventricular wall thickness and total left ven-
tricular myocardial mass. See Online Videos 1 and 2. LVH  left
ventricular hypertrophy.B B R E V I A T I O N S
N D A C R O N YM S
D 2-dimensional
D 3-dimensional
F atrial fibrillation
MR cardiac magnetic
esonance
FNEF heart failure with
ormal ejection fraction
FREF heart failure with
educed ejection fraction
A left atrial
GE late gadolinium
nhancement
V left ventricular
VEF left ventricular ejectunction. Grade III diastolic dysfunction is charac-
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411erized by very abrupt flow of blood from left atrium
nto left ventricle, but with reversibility with the
alsalva maneuver. Grade IV diastolic dysfunction
s characterized by irreversibility with the Valsalva
aneuver.
ssessment of Systolic LV Function
chocardiography. A sine qua non in the diagnosis of
FNEF is the establishment of normal LVEF. Tra-
itional measurement of LVEF by 2-dimensional
2D) echocardiography relies on clear endocardial
efinition, which is lacking in up to 31% cases (7),
articularly when intravenous contrast is not uti-
ized. LVEF in patients with clinical heart failure is
unimodally distributed continuous variable. Thus,
he cutoff of 50% to dichotomize HFNEF from
FREF is somewhat arbitrary. Nonetheless, repro-
ucible assessment of LV volumes is crucial in
elineating the predominant pathogenic mecha-
isms underlying a patient’s heart failure. Even in
he hands of expert echocardiographic laboratories,
here is considerable variability in the estimation of
VEF (8). Furthermore, there is poor agreement
etween Simpson’s biplane technique and CMR
maging, the imaging gold standard for estimation
f cardiac volumes, with Bland-Altman limits of
greement of up to 20% among a sample of heart
ailure patients (7).
In 3-dimensional (3D) echocardiography, data
re acquired over 4 to 6 cardiac cycles then synthe-
ized into a single so-called full-volume dataset.
his can then be manipulated or cropped to obtain
onforeshortened planes through the left ventricle,
hus permitting more accurate estimation of cham-
er volumes. Three-dimensional echocardiography
oasts superior reproducibility and closer approxi-
ation to CMR than 2D echo in the measurement
f LVEF (9). Despite minimal bias compared with
MR, 3D echo has slightly greater variability (10).
his may relate to poorer spatial resolution and
ndocardial definition, which is suboptimal in up to
0% of cases, and is associated with less reliable
easurement of LV volumes compared with non–
ndocardial-dependent techniques (11). Three-
imensional echocardiography and CMR both re-
uire the patient to breath-hold during image
cquisition, which can prove difficult in those dys-
neic at rest.
Although accurate and reproducible measure-
ent of LVEF is clearly desirable, it is not always
easible in clinical practice, where patient character-
stics often differ greatly from those studied in the aesearch setting. Obstacles such as the inability to
dequately position bed-bound patients, ventilator
ependency in the intensive care unit, and comor-
idities such as chronic obstructive pulmonary dis-
ase and obesity frequently render accurate mea-
urement of LVEF limited using conventional echo
echniques. Contrast echocardiography and tissue
oppler imaging may potentially have a role to play
n this setting. Contrast-enhanced 2D echocardi-
graphy has similar accuracy to noncontrast 3D
chocardiography (12). Contrast-enhanced 3D
chocardiography may yield even superior results
12). Peak systolic tissue velocity (Sm) by pulse
ave tissue Doppler at the mitral annulus has been
hown to correlate with LVEF. Sm 7 cm/s
redicts LVEF 45% with sensitivity 93% and
pecificity 87% (13). Tissue velocity in this location
epresents an integral of longitudinal cardiac mo-
ion from base to apex. The advantage of tissue
oppler imaging is that it is not reliant on good 2D
mage quality and has good reproducibility.
Speckle tracking technology provides another
chocardiographic means to evaluate systolic LV
unction. It relies on tracking small myocardial
egions of interest, each with a relatively unique
ppearance owing to its pattern of acoustic back-
catter, through space from frame to frame. This
hen permits calculation of strain—tissue deforma-
ion—on a regional basis. Current software allows
egional strain scores to be averaged to yield a global
train score. This score has been proven an accurate
ndex of systolic LV function in chronic ischemic
eart disease (14). Global strain score’s advantage
ver LVEF as an index is its reproducibility, al-
hough its prognostic role remains to be deter-
ined. Furthermore, strain analysis permits inter-
ogation of myocardial deformation in any cardiac
xis. Wang et al. (15) recently demonstrated that
ongitudinal and radial systolic strains are reduced
n diastolic heart failure although LV twist is
reserved.
MR imaging. CMR has rapidly become the imag-
ng method of choice and the gold standard in the
ssessment of systolic cardiac function of both
ormal and abnormal left ventricles (7). With
egard to measurement of global LV systolic func-
ion, given its 3D nature and an order of magnitude
reater signal-to-noise ratio, CMR is highly supe-
ior to 2D echo (7). Given its greater reproducibility
n measuring LVEF over 2D echo, the potential for
rroneously categorizing heart failure is markedly
essened. This imaging is typically performed in,
lthough not limited to, the conventional short-axis
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412iews (Online Video 1) and the 3 cardinal long-axis
iews (Online Video 2). The ability of CMR to
mage in any plane without the need for optimal
maging windows allows for unprecedented flexibil-
ty for the interrogation of abnormal heart
tructures.
Cine images are obtained using steady-state free
recession sequences, which provide images of
igher signal to noise (than older sequences such as
radient echo), and hence exceptional delineation of
he blood–myocardium interface. This allows for
ccurate and reproducible quantitative assessment
f chamber dimensions and systolic function using
anual or semiautomated planimetry techniques.
Visual inspection of LV and right ventricular
rchitecture identifies patterns of regional or diffuse
all thinning and concentric or asymmetric hyper-
rophy. Pericardial thickness and calcification can
e assessed. The spatial resolution with which this
an be achieved by CMR is useful in distinguishing
ericardial constriction from restrictive cardiomy-
pathy, both of which may result in features of
c Patterns of LGE and Ancillary Findings on CMR Imaging in
s That May Present as HFNEF
Pattern of Late
Gadolinium
Enhancement
Prevalence of
Late Gadolinium
Enhancement* Ancillary Findings
-wall within
ypertrophied
egments in patchy
istribution
st consistently at
nterior and
osterior junction of
nterventricular
eptum and right
entricular free wall
79%–81% LV hypertrophy, usually
asymmetric
st often basal
nferolateral wall
endocardium
sually spared
50% LV hypertrophy—may
be indistinguishable
from HCM. Biopsy or
genetic testing
conﬁrms diagnosis
use
endocardial but
raversing arterial
erritories
69% Multiple images of the
same view using
different inversion
times may allow
demonstration of
diffuse early nulling
of myocardial signal
to suggest
amyloidosis
presence of
ericardial
nhancement
uggests ongoing
nﬂammation
— Pericardial thickness
4 mm is consistent
with the diagnosis,
and 5 mm has
high speciﬁcity
he cited references and represent the best available estimate of late gadolinium
tual prevalence may vary with the population studied.
resonance; HCM  hypertrophic cardiomyopathy; HFNEF  heart failure with
GE  late gadolinium enhancement; LV  left ventricular.teart failure with normal ejection fraction. Tomo-
raphic imaging is an important adjunct to echo-
ardiographic characterization of hemodynamics,
hich forms the cornerstone of diagnosing pericar-
ial constriction, especially given the observation
hat constriction may occur in the absence of
ericardial thickening.
CMR tagging is a technique by which a radio-
requency pulse is applied to LV myocardium in the
orm of grid lines. The tagged grid deforms as the
aturated myocardium moves throughout the car-
iac cycle, allowing regional strain to be visualized
nd quantified. The tag is generally applied at the
nset of systole, triggered by the ECG R-wave, and
ades during the cardiac cycle as the magnetization
ecovers towards equilibrium as a result of spin-
attice, or T1, relaxation. Measurement of strain is
uited to quantifying regional systolic LV function.
The tissue phase mapping technique allows the
etermination of 3D velocity tensors over the car-
iac cycle, i.e., for rotation, radial, and longitudinal
ovement, with a pixel-by-pixel spatial resolution
earing that of “conventional” cine CMR (16). This
as been investigated in clinical studies in both pa-
ients and volunteers, and newer navigator sequences
obviating the need for breath-holding, and hence
ith the potential for improving spatial resolution)
ave been developed. Displacement-encoded imaging
sing stimulated echoes (DENSE) can also provide
nformation on myocardial displacement, velocity, and
train (17).
issue Characterization
he development of the late gadolinium enhance-
ent (LGE) CMR technique (LGE-CMR) has
evolutionized the role of CMR in clinical and
esearch practice. It has a potential role in the
ontext of HFNEF, in identifying specific patterns
f fibrosis and scarring in many of the cardiomyop-
thy states that may initially present with HFNEF
18,19). This is summarized in Table 1. There is a
igh prevalence (79% to 81%) of late gadolinium
nhancement in hypertrophic cardiomyopathy
18,20). Its distribution is typically mid-wall within
ypertrophied segments, and is particularly promi-
ent at the junction of the interventricular septum
nd right ventricular free wall (20) (Fig. 2). Fabry
isease, caused by X-linked alpha-galactosidase de-
ciency, may be difficult to distinguish echocardio-
raphically from hypertrophic cardiomyopathy.
his distinction is important because disease-Table 1. Characteristi
Various Disease State
Disease (Ref. #)
HCM (18,20) Mid
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413isease. LGE occurs in 50% of cases, and if present,
sually affects the basal inferolateral wall, sparing the
ubendocardium (21). Amyloidosis has been found to
e associated with qualitative global and subendocar-
ial gadolinium enhancement of the myocardium. A
ecent landmark study found that subendocardial lon-
itudinal relaxation time (T1) in amyloid patients was
horter than in controls, and was correlated with
arkers of increased myocardial amyloid load, such as
V mass, wall thickness, interatrial septal thick-
ess, and diastolic function. Global subendocar-
ial LGE was found in approximately two-thirds
f patients (22). The T2* CMR technique, which
s noncontrast-dependent, has been shown to be
aluable in the quantification of myocardial iron
eposition in hemochromatosis (23).
ssessment of Left Atrial Volume
eft atrial (LA) size is an important prognostic
arker in a number of cardiovascular disease states
24,25). It can be considered as an end point of
umulative LV insult. LA dilation can help dis-
riminate normal from pseudonormal LV filling
26), and its finding in the appropriate clinical
etting supports the diagnosis of HFNEF (27). A
arge cross-sectional study has shown the associa-
Figure 2. End-Diastolic Images From a Patient With Hypertroph
(A) Short-axis white blood cardiac magnetic resonance (CMR) image
gadolinium-enhancement CMR image demonstrating increased sign
ventricular free wall (arrows). (C) Vertical long-axis white blood CM
axis late gadolinium-enhancement CMR image demonstrating increasion between LA volume (indexed to body surface mrea) and grade of diastolic dysfunction with an area
nder the receiver-operator characteristic curve of
.81 to detect grade II diastolic dysfunction (28).
chocardiography. As with assessment of LV cavity
ize, quantification of LA size has progressed from
ingle-dimension measurement by M-mode echocar-
iography to single-plane and biplane estimation of
rea and volume. Prognostic discriminatory power
ncreases with each step’s increase in data. Among 2D
echniques used to assess LA volume Simpson’s bi-
lane and the area-length method have the closest
orrelation, whereas the prolate-ellipsoid technique
nderestimates LA volume (29). More recently, 3D
chocardiography has been used to evaluate LA vol-
me (30). This technique has superior test-retest
eliability and inter- and intraobserver variability to
ther echocardiographic techniques (31).
agnetic resonance imaging. Early studies deter-
ined reference ranges for LA dimensions and area
32). Subsequent studies examined the accuracy of
easurement of LA volume by either a modified
i-plane Simpson’s technique from the horizontal
nd vertical long axes (33), or by measurement from
short axis stack (34). The inter- and intraobserver
ariability and interstudy variability tend to be
reater when LA volume is measured using the
ardiomyopathy
monstrating asymmetric septal hypertrophy. (B) Short-axis late
tensity at the junction of the interventricular septum and right
age demonstrating left ventricular hypertrophy. (D) Vertical long-
ignal intensity in the anterior wall (arrow). See Online Video 3.ic C
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414s generally included in the LA volume, but pulmo-
ary veins are excluded.
ssessment of LVMass
here is a well-recognized association between LV
ass and adverse cardiovascular outcomes and even
udden cardiac death (36). This relationship persists
fter adjustment for conventional cardiovascular
isk factors. This association likely holds true be-
ause LV mass, like LA volume, represents an end
oint of cumulative LV insult. Although not a
iagnostic criterion for HFNEF, increased LV
ass provides supportive evidence. Furthermore, it
s conceptually attractive to quantify LV mass as it
elates directly to the pathological process underly-
ng HFNEF, although further investigation is
eeded to truly relate the anatopathologic defect of
V mass to that of the physiologic perturbation of
iastolic function.
chocardiography. Early echocardiographic tech-
iques for measuring LV mass that relied on
-mode have been superseded by 2D and, more
ecently, 3D techniques. Each advance in echocar-
iographic methodology has resulted in fewer in-
erent assumptions and thus more accurate and
eproducible measurement of LV mass. 3D echo-
ardiographic measurement of LV mass is more
eproducible than 2D, and approximates CMR
ore closely (37), whereas 2D techniques suffer
rom wide limits of agreement (38).
MR. CMR is the noninvasive gold standard for
easurement of LV mass (39) and has been vali-
ated against cadaveric measurements (40). Normal
anges for LV mass by CMR have been published
41). The technique for measurement of LV myo-
ardial volume requires manual or semiautomated
Table 2. Echocardiographic Classiﬁcation of Grades of Diastolic
Parameter Normal
Mild Dysfunction
(Grade 1)
M
Transmitral PW Doppler
E/A 1–1.5 1
DT (ms) 140–250 250
TDI
E’ (cm/s) 7 7
Valsalva Negative Positive
LAVI (ml/m2) 22 6 28
Pulmonary venous ﬂow S D S D
Mitral in-ﬂow propagation
velocity (cm/s)
50 50
D  peak D-wave velocity; DT  deceleration time; E/A  ratio of E- to A-wave
S  peak S-wave velocity; TDI  pulse wave tissue Doppler imaging at the sepndo- and epicardial border tracing. LV mass is aalculated by multiplying this volume by 1.05g/cm3
the specific density of myocardium). The greater
ccuracy and reproducibility of CMR in the mea-
urement of LV mass allow smaller changes to be
etected (Online Videos 1 to 3). This provides
reater sensitivity to measure the effects of disease
rogression or efficacy of disease therapy.
ssessment of Diastolic LV Function
chocardiography. Echocardiography is the imaging
echnique of choice in evaluation of diastolic function.
mong the parameters available for echocardio-
raphic assessment of diastolic function (Table 2),
ransmitral flow velocities and tissue Doppler imag-
ng are the quickest to acquire and have the lowest
nterobserver variability (42). In healthy, young
ndividuals, most LV filling occurs in early diastole,
esulting in a prevailing E-wave. With aging or
iastolic dysfunction, increasing LV stiffness and
mpaired diastolic LV untwisting reduces early LV
lling, thus resulting in a predominant A-wave. As
iastolic dysfunction progresses to pseudonormal-
ty, LA pressure rises, and early LV filling increases
n proportion. Despite an E/A ratio 1, the patho-
hysiological distinction from normality is that
arly LV filling is from blood being forced in rather
han being sucked in. In grade III diastolic dysfunc-
ion, the E/A ratio is 2 and deceleration time
140 ms (Fig. 3). Although the finding of a
estrictive transmitral filling profile allows easy rec-
gnition of diastolic dysfunction, this pattern is
nly observed in 10% of cases of HFNEF (4).
ccasionally, a triphasic pattern of transmitral fill-
ng is observed (Fig. 4) as an L-wave: antegrade
ow resulting in a Doppler signal between the E
function
rate Dysfunction
(Grade 2)
Severe Dysfunction
(Grade 3)
Severe Dysfunction
(Grade 4)
1–1.5 2 2.5
140–250 140 140
7 5 5
Positive Positive Negative
28 35 40
S D S D S D
50 50 50
ities; LAVI  left atrial volume indexed to body surface area; PW  pulse wave;
itral annulus.Dys
ode
velocnd A waves, during what is normally diastasis.
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415lthough not necessarily pathognomonic for severe
iastolic dysfunction, the L-wave has a predilection
or occurrence in those with significant LV pathol-
gy, and thus may be supportive of diastolic dys-
unction (43).
A challenge in diastology is the distinction of
seudonormal filling from normal. Of assistance in
his regard are (Table 2): 1) the Valsalva maneuver,
hich results in reversal in E/A ratio in pseudonor-
ality, but not in normality (Fig. 5B); 2) tissue
oppler imaging at the mitral annulus, where E=
7 cm/s suggests diastolic dysfunction, and E= 5
m/s strongly supports it (Fig. 5C); 3) pulmonary
enous Doppler (Fig. 5D); 4) propagation of mitral
n-flow towards the apex using color M-mode (44);
) systolic LV function—if impaired, suggests con-
omitant diastolic dysfunction; 6) LV hypertrophy,
hich suggests diastolic dysfunction; and 7) LA
ilation, which also supports the diagnosis of dia-
tolic dysfunction. Caution must be exercised rely-
ng solely on E/A ratio: following cardioversion or
pontaneous reversion to sinus rhythm from atrial
brillation the A-wave is reduced owing to atrial
tunning. This can give a misleadingly high E/A
atio. Moderate or greater mitral valve disease poses
similar caveat.
Peak early diastolic mitral velocity (E) is influ-
nced by LA pressure, age, and LV relaxation,
hereas peak diastolic mitral annular tissue velocity
E=) is governed by age and LV relaxation. Thus the
/E= ratio is, theoretically, a measure of LA pres-
ure. E/E= has been shown to have a better corre-
ation with LV end-diastolic pressure (LVEDP)
han other echocardiographic indices, with a ratio
15 predicting elevated mean LVEDP (45). It is
gain important to be aware of a technique’s limi-
Figure 3. Doppler Evaluation of a Patient With Restrictive LV Fi
(A) Transmitral pulsed wave Doppler at mitral valve leaﬂet tips dem
Pulsed wave Doppler at the ostium of the right upper pulmonary v
ties; LV  left ventricular.ations. If septal motion is abnormal, for instance asresult of right ventricular pacing or left bundle
ranch block, E/E= has been shown unreliable for
he prediction of pulmonary capillary wedge pres-
ure (46). Nonetheless, in a study of patients 1.6
ays following myocardial infarction, 42% of
hich were anterior, E/E= was a superior prog-
ostic index to other clinical and echocardio-
raphic parameters (47).
MR. In contrast to the wealth of studies in LV
ystolic dysfunction, there is relative inexperience in
MR assessment of diastolic LV function. None-
heless, a number of CMR techniques have been
sed to evaluate diastolic function. Peak LV filling
ates in early and late diastole can be measured by
ates of change in chamber volume—a technique
ade possible by CMR’s high spatial resolution. It
as been demonstrated that their ratio decreases
Figure 4. Diastolic L-Wave on Transmitral Doppler Echocardiogr
Transmitral pulsed wave Doppler at mitral valve leaﬂet tips in a pat
pseudonormal left ventricular ﬁlling. An L-wave is seen as antegrad
trating E/A ratio 2 and brief deceleration time (arrows). (B)
showing S-wave  D-wave. E/A  ratio of E- to A-wave veloci-aphy
ient with
e ﬂowlling
ons
einoccurring between the E and A waves.
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416ith age in healthy individuals, in a manner anal-
gous to E/A ratio by transmitral Doppler echo
48). Volume-derived indices such as peak early and
ate LV filling rate and time to peak early LV filling
ave been promoted as sensitive markers of diastolic
ysfunction (49), but their measurement remains
ighly time-consuming with present software and
mpractical from a clinical perspective.
Blood flow velocity can be measured by CMR.
hase-contrast imaging, in which the spin phase
hift is used to estimate transmitral blood flow
elocity, has demonstrated at least moderate corre-
ation with echocardiography (50,51), although
5% confidence limits on Bland-Altman analysis
re wide. Velocities measured by CMR tend to be
ower than by echocardiography as a consequence of
he lower temporal resolution of CMR. Temporal
esolution may be improved by reducing number of
iews/segment; however, this requires longer
reath-hold times.
Studies have employed myocardial grid tagging
o demonstrate abnormalities in LV untwisting in
iastole in conditions such as aortic stenosis (52).
o date, the major limitation in myocardial grid
agging for the assessment of diastolic function has
een the fading of grid lines over the course of the
ardiac cycle. In a large population study of subjects
Figure 5. Doppler Evaluation of a Patient With Pseudonormal L
(A) Transmitral pulsed wave Doppler at mitral valve leaﬂet tips. (B)
Valsalva maneuver illustrating E/A reversal. (C) Pulsed-wave tissue D
diastolic E= velocity. (D) Pulsed wave Doppler at the ostium of the r
ventricular.ithout known cardiovascular disease, early dia- ttolic strain rate (the first temporal derivative of
train) could be measured in 80% of segments
nalyzed (53). Atrial-induced strain rate could be
ssessed in only 32% of patients. In the remainder,
ag lines faded in intensity, precluding analysis.
lthough this study found early diastolic strain rate
nversely proportional to indexed LV mass, it high-
ights the current limitations of CMR in assessing
iastolic function. Imaging sequences with higher
emporal resolution have been shown to increase
he proportion of the cardiac cycle that can be
nalyzed over older fast-gradient echo sequences. A
.0-T CMR has been shown to produce better tag
ersistence through the cardiac cycle than 1.5-T
nd might have a role in the future (54).
Velocity-encoded CMR or tissue-phase mapping
as been used to evaluate regional systolic and
iastolic tissue velocities in an analogous manner to
chocardiography (55,56). It has superior spatial
esolution to grid tagging because the number of
rid lines that can be placed on the myocardium
imits the latter. Tissue-phase mapping also encom-
asses more of the cardiac cycle than grid tagging.
espite its feasibility, tissue-phase mapping has not
ained widespread popularity in the evaluation of
iastolic function, mainly due to poorer temporal
esolution and difficulty with the long breath-hold
lling
smitral pulsed wave Doppler at mitral valve leaﬂet tips during
ler imaging at the septal mitral annulus demonstrating reduced
upper pulmonary vein showing S-wave  D-wave. LV  leftV Fi
Tran
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ightimes required, which is of particular relevance in
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417he heart failure population. Bergvall et al. (57) have
alidated tissue-phase mapping during free breath-
ng against grid tagging. Fading of the grid lines in
iastole limited the validation of diastolic tissue
elocities, however.
In summary, although early studies show promise
n CMR assessment of diastolic function, present
imitations and the time-consuming nature of data
cquisition restrict the widespread implementation
f these techniques.
trial Fibrillation
trial fibrillation (AF) poses a challenge to the
valuation of cardiac function. Variability in cycle
ength hinders estimation of LV function by any
odality because of beat-to-beat variation in LV
lling and ejection. Furthermore, loss of the
-wave precludes measurement of the E/A ratio.
t is recommended that measurements taken in
F be averaged over at least 5 cardiac cycles,
lthough this may have workflow implications in
usy laboratories.
Modest correlation exists between transmitral
eceleration and pulmonary capillary wedge pres-
ure, although the clinical utility of this is limited
58). The E/E= ratio remains of value in the
iagnosis of HFNEF in the presence of AF. In a
ross-sectional study of patients with HFNEF,
eptal E/E= 13 corroborated the diagnosis with
ensitivity 81.8% and specificity 89.5% (59). An
bservational study of nonvalvular AF demon-
trated that E/E= 15 is an independent predictor
f mortality (60). Pulmonary venous flow profiles
ay be of use in AF. A deceleration time of the
-wave 220 ms has been shown to predict mean
ulmonary capillary wedge pressure 12 mm Hg
ith 100% sensitivity and specificity (58). Although
A volume reflects prevailing LV function, its
iscriminatory role in AF is confounded by the fact
hat AF itself promotes LA dilation.
uture Directions
resent-generation matrix array probes that permit
eal-time 3D echocardiographic imaging are large
n size, rendering them unwieldy. As their dimen-
ions decrease, a greater proportion of individuals
ill be able to benefit from 3D echocardiography.
urrent echocardiographic acquisition of myocar-
ial tissue velocity or strain data utilizes sequential
mages in different 2D planes. The inherent limi-
ation that results is from possible beat-to-beat
ariability in myocardial function. The development if 3D probes that permit real-time recording of
issue velocity or deformation information may
ake accurate characterization of all aspects of
yocardial function more rapid and reliable.
Nonangulated 3D CMR images of the heart
cquired even during free breathing has shown
romise in overcoming some of the limitations of
MR estimation of LVEF (61). Emerging CMR
echniques that allow mapping of blood flow may
llow more accurate characterization of LV filling
inetics (62). The temporal and prognostic rela-
ionship between myocardial fibrosis and HFNEF
arrants further investigation. Tools such as LGE-
MR and integrated echocardiographic backscatter
re available to quantitate myocardial fibrosis, but
hether this adds incrementally useful data in the
iagnosis of HFNEF is uncertain. The major lim-
tation of LGE in the detection of myocardial
brosis is that it relies on difference in signal
ntensity between scarred regions and adjacent nor-
al myocardium. It may thus have reduced sensi-
ivity for diffuse fibrosis. The calculation of a
ost-contrast myocardial T1 time following imag-
ng a given plane with sequentially increasing in-
ersion times has recently been shown to discrimi-
ate heart failure patients from healthy controls
ven after excluding myocardial segments display-
ng LGE. This technique shows promise in more
ensitive and quantitative evaluation of myocardial
brosis (63).
Imaging of blood flow propagation and vorticity
s currently under development. Its advent will
llow greater characterization of the relationship
etween LV filling and ejection. Lastly, fusion
maging, which integrates data from more than 1
odality, may permit the advantages of different
echniques to become fully integrated.
onclusions
wo of the 3 criteria for diagnosis of HFNEF are
ependent on cardiac imaging. Echocardiography
nd CMR are the 2 modalities that offer the most in
his regard because they obtain data on cardiac
tructure and function, in contrast to scintigraphy.
hey each have strengths and limitations that at
resent make them complementary. Echocardio-
raphy’s high temporal resolution makes it the
odality of choice for assessing diastolic function,
hereas CMR’s high spatial resolution permits
recise evaluation of systolic function. Although
MR suffers from limited availability, and contra-ndications such as implantable metallic devices, its
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418bility to obtain accurate information in patients
ith poor echocardiographic windows makes it an
mportant alternative in the diagnosis and charac-
erization of heart failure. Each modality has made
ecent progress to address their respective areas of
eakness. If appropriate echo windows are avail-
ble, 3D echo approaches CMR in the estimation
f LVEF. Advances in CMR sequences increas-dimensional echocardiography versus Magn Reson Imaginoth imaging modalities are not necessary for the
iagnosis of HFNEF in the majority of cases,
ncertainty following 1 scan may be resolved by
tilizing the strengths of the other.
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